XML 52 R35.htm IDEA: XBRL DOCUMENT v3.26.1

DERIVATIVES (Tables)

3 Months Ended

Mar. 31, 2026

DERIVATIVES

Schedule of fair values of derivative instruments on the Company's Consolidated Balance Sheets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

March 31, 2026

​

December 31, 2025

​

Other

​

Other

​

​

​

​

​

​

​

Other

​

Other

​

​

​

​

​

​

​

Current

​

Current

​

Other

​

Other

​

Current

​

Current

​

Other

​

Other

Derivatives by hedge designation

Assets

​ ​ ​

Liabilities

​ ​ ​

Assets

​ ​ ​

Liabilities

​ ​ ​

Assets

​ ​ ​

Liabilities

​ ​ ​

Assets

​ ​ ​

Liabilities

Designated as hedging instruments:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Foreign exchange contracts

$

1,507

​

$

482

​

$

—

​

$

—

​

$

2,149

​

$

289

​

$

—

​

$

—

Net investment contracts

​

3,784

​

​

1,255

​

​

—

​

​

—

​

​

102

​

​

12,529

​

​

—

​

​

—

Not designated as hedging instruments:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Foreign exchange contracts

1,419

​

​

1,587

​

​

—

​

​

—

​

582

​

470

​

—

​

—

Total derivatives

$

6,710

​

$

3,324

​

$

—

​

$

—

​

$

2,833

​

$

13,288

​

$

—

​

$

—

Schedule of effects of undesignated derivative instruments on the Company's Consolidated Statements of Income

​

​	​	​	​	​	​	​	​	​
​	​	​	​	Three Months Ended March 31,
Derivatives by hedge designation	​ ​ ​	Classification of (loss) gain	​ ​ ​	2026		​ ​ ​	2025
Not designated as hedges:	​	​	​	​	​		​	​
Foreign exchange contracts	​	Selling, general & administrative expenses	​	$	(3,353)	​	$	8,333

Schedule of effects of designated cash flow hedges on AOCI and the entity's Consolidated Statements of Income

​

​	​	​	​	​	​	​
​	​ ​ ​	​	​	​	​	​
Total gain (loss) recognized in AOCI, net of tax	​ ​ ​	March 31, 2026		​ ​ ​	December 31, 2025
Foreign exchange contracts	​	$	642	​	$	1,396
Forward starting swap agreements	​	​	15,722	​	​	16,291
Net investment contracts	​	​	(4,179)	​		(5,721)

​

​	​	​	​	​	​	​	​	​
​	​	Gain (loss) recognized in the	​	Three Months Ended March 31,
Derivative type	​ ​ ​	Consolidated Statements of Income:	​ ​ ​	2026		​ ​ ​	2025
Foreign exchange contracts		Sales	​	$	1,472	​	$	(713)
​		Cost of goods sold	​		1,560	​		361
Forward starting swap agreements	​	Interest expense, net	​	​	689	​	​	689

​

X

- References

No definition available.

+ Details

Name:	us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

+ Details

Name:	us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration